Effects of lipopolysaccharide and interleukin-6 on cataleptic immobility and locomotor activity in mice

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 302-304

  Bazovkina, Daria V ^a   Tibeikina, Marina A ^a   Kulikov, Alexander V ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Catalepsy; Interleukin 6; Lipopolysaccharide; Locomotor activity; Mice

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; CYTOKINE RELEASE; DEFENSIVE BEHAVIOR; HYPNOSIS; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL;

ANIMALS; FREEZING REACTION, CATALEPTIC; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY;

EID: 78650521504     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.043     Document Type: Article

References (32)

1. Alperina E.L., Kulikov A.V., Popova N.K., Idova G.V. Immnune response in mice of a new strain ASC (antidepressants sensitive catalepsy). Bull. Exp. Biol. Med. 2007, 144:221-223.
2. Amir S., Brown Z.W., Amir Z., Ornstein K. Body-pinches induced long lasting cataleptic-like immobility in mice: behavioral characterization and the effects of naloxone. Life Sci. 1981, 10:1189-1194.
3. Anisman H., Merali Z., Poulter M.O., Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 2005, 11:963-972.
4. Bazovkina D.V., Kulikov A.V., Kondaurova E.M., Popova N.K. Selection for predisposition to catalepsy enhances depressive-like traits in mice. Russ. J. Genet. 2005, 41:1222-1228.
5. Chesnokova V., Melmed S. Minireview: neuro-immunoendocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002, 143:1571-1574.
6. Dixon A.K. Ethological strategies for defense in animals and humans: their role in some psychiatric disorders. Br. J. Med. Psychol. 1998, 71:417-445.
7. Dunn A. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 2006, 6:52-68.
8. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
9. 9-tetrahydrocannabinol-induced catalepsy in mice. Pharmacol. Biochem. Behav. 1995, 50:141-146.
10. Hayley S., Poulter M.O., Merali Z., Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005, 135:659-678.
11. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflamation, sickness behavior and anhedonia. J. Neuroinflamation 2008, 5:1-14.
12. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1 and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
13. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
14. Klemm W.R. Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 1989, 32:403-422.
15. 1A serotonin receptor gene in mice. Genes Brain Behav. 2006, 5:596-601.
16. Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Popova N.K. Genetic structure of hereditary catalepsy in mice. Genes Brain Behav. 2008, 7:506-512.
17. Kulikov A.V., Bazovkina D.V., Moisan M.-P., Mormede P. The mapping of the gene of susceptibility to catalepsy in mice using polymorphic microsatellite markers. Dokl. Biol. Sci. 2003, 393:531-534.
18. Kulikov A.V., Kolpakov V.G., Popova N.R. The Genetic Catalepsy (GC) Rat Strain as a Model of Depressive Disorders 2006, 59-73. Nova Sci. Publ., New York. A.V. Kalueff (Ed.).
19. Kulikov A.V., Kozlachkova E., Kudryavtseva N.N., Popova N.K. Correlation between tryptophan hydroxylase activity in the brain and predisposition to pinch-induced catalepsy in mice. Pharmacol. Biochem. Behav. 1995, 50:431-435.
20. Kulikov A.V., Kozlachkova E., Maslova G., Popova N.K. Inheritance of predisposition to catalepsy in mice. Behav. Genetics 1993, 23:379-384.
21. Kulikov A.V., Kozlachkova E., Popova N.K. The activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats. Pharmacol. Biochem. Behav. 1992, 43:999-1003.
22. Kulikov A.V., Popova N.K. Genetic control of catalepsy in mice. Genetic Predisposition to Disease 2008, 215-236. Nova Sci. Publ., New York. S. Torres, M. Martin (Eds.).
23. Kulikov A.V., Tikhonova M.A., Kulikov V.A. Automated measurement of spatial preference in the open field test with transmitted lighting. J. Neurosci. Methods 2008, 170:345-351.
24. O'Neill L.A.J., Greene C. Signal transduction pathways activated by the Il-1 receptor family: ancient signaling machinery in mammals, insects and plants. J. Leukoc. Biol. 1998, 63:650-657.
25. Singerman B., Raheja R. Malignant catatonia - a continuing reality. Ann. Clin. Psychiatry 1994, 6:259-266.
26. Sano K., Mishima K., Koushi E., Orito K., Egashira N., Irie K., Takasaki K., Katsurabayashi S., Iwasaki K., Uchida N., Egawa T., Kitamura Y., Nishimura R., Fujiwara M. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 2008, 151:320-328.
27. Swiergiel A.H., Dunn A.J. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav. Brain Res. 2006, 171:94-108.
28. Swiergiel A.H., Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 2007, 86:651-659.
29. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. Am. J. Psychiatry 2003, 160:1233-1241.
30. Yirmiya R., Polak Y., Barak O., Avitsur R., Ovadia H., Bette M., Weihe E., Weidenfeld J. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001, 24:531-544.
31. Zhang J.-J., Terreni L., De Simoni M.-G., Dunn A.J. Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem. Int. 2001, 38:3003-3308.
32. Zubareva O.E., Efremov O.M., Simbirtsev A.S., Klimenko V.M. Interleukin-1beta and depressive states. Ross. Fiziol. Zh. Im. I M Sechenova 2001, 87:1450-1456.